Skip to main content
ELAB
NASDAQ Life Sciences

PMGC Puts $1.845M Into Nuclea Canada Debentures Tied to Moltex Deal and Its Own SPAC

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$2.12
Mkt Cap
$1.708M
52W Low
$1.84
52W High
$1,491.816
52W Position info
15% above low
Off High info
100% below high
Rel. Volume info
52× avg
Market data snapshot near publication time

ELAB sits 15% above its 52-week low of $1.84 on elevated volume (52× avg).

Summary

PMGC Holdings subscribed for $1.845 million of non-interest-bearing secured debentures of Nuclea Energy Canada, the company buying Moltex Energy's assets ahead of a merger with PMGC-sponsored SPAC NorthStrive Acquisition Corp. I. PMGC earns a $45,000 finance fee and holds about 20.5% of the debentures, with funds escrowed until the Moltex acquisition closes.


Key Events · M&A and Partnerships · ELAB

  • PMGC Subscribes for $1.845M of Nuclea Debentures

    On October 30, 2026, PMGC agreed to buy 1,845 secured debentures of Nuclea Energy Canada Inc. at US$1,000 each, US$1,845,000 in total, as part of a Nuclea offering of up to US$9,000,000.

  • $45,000 Finance Fee, No Interest

    The debentures bear no interest and mature three months from issuance; PMGC's compensation is a US$45,000 finance fee withheld from the subscription price as an original issue discount, roughly 2.4% of the amount subscribed.

  • Escrow Until Moltex Acquisition Closes

    Proceeds are held by OceanFirst Bank N.A. and released to Nuclea only when the Moltex Energy asset purchase conditions are met; if not satisfied within 60 days, or on termination events, the funds return to subscribers.

  • Related-Party Deal With Own SPAC

    PMGC is managing member of NorthStrive Sponsor I LLC, sponsor of NorthStrive Acquisition Corp. I, which has a business combination agreement with Nuclea Energy Inc.; PMGC is also an existing Nuclea Energy Inc. investor, and the board approved the transaction.


Analysis · ELAB · Life Sciences

PMGC is recycling cash into a related-party financing: it is buying $1.845 million of Nuclea Energy Canada's secured debentures, the vehicle raising money to buy Moltex Energy's assets before being taken public through NorthStrive Acquisition Corp. I — the SPAC PMGC sponsored and took public on October 1. Because the debentures pay no interest and mature in three months, the return is the $45,000 finance fee (about 2.4% of the subscription) plus repayment of principal, not a yield. Timing is the real risk: the money sits in escrow at OceanFirst Bank until the Moltex acquisition conditions are met, and comes back to subscribers if they are not satisfied within 60 days. For a company that reported a $7.9M first-half loss and a going concern warning in August, tying up $1.845M in a three-month escrow is a meaningful liquidity commitment. The related-party structure — overlapping officers and directors with NSAI, plus PMGC's existing stake in Nuclea Energy Inc. — means the board's approval is the only check on terms.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ELAB was trading at $2.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7M. The 52-week trading range was $1.84 to $1,491.82. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ELAB - Latest Insights

ELAB
Nov 16, 2026, 7:30 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.63
Real-time Price: $1.44 info
Change: -$0.1931 (-12%) info
Market Cap: $1.19M info
ELAB
Nov 13, 2026, 4:00 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.58
Real-time Price: $1.44 info
Change: -$0.1424 (-9%) info
Market Cap: $1.19M info
ELAB
Oct 01, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $3.62
Real-time Price: $1.44 info
Change: -$2.18 (-60%) info
Market Cap: $1.19M info
ELAB
Sep 18, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $4.70
Real-time Price: $1.44 info
Change: -$3.26 (-69%) info
Market Cap: $1.19M info
ELAB
Sep 02, 2026, 5:04 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.20
Real-time Price: $1.44 info
Change: -$3.76 (-72%) info
Market Cap: $1.19M info